Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion

Cancer Research

Volumn 56, Issue 23, 1996, Pages 5369-5374

  Simon, Christian ^a   Juarez, Jose ^a   Nicolson, Garth L ^b   Boyd, Douglas ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Institute for Molecular Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR ALPHA; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; ENZYME INDUCTION; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; ISOFLAVONES; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030468743     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Ossowski, L , Russo-Payne, H., and Wilson, E Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse. Cancer Res., 51: 274-281, 1991.
2. Tryggvason, K., Hoyhtya, M , and Salo, T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta. 907, 191-217, 1987.
3. Markus, G. The relevance of plasminogen activators to neoplastic growth Enzyme, 40: 158-172, 1988.
4. Presta, M., Mater, A., Rusnati, M., Moscatelli, D , and Ragnotti, G. Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor b. Cancer Res., 48: 6384-6389, 1988.
5. Rorth, P., Nerlov, C., Blasi, F., and Johnsen, M. Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acids Res., 18: 5009-5017, 1990.
6. Pepper, M. S., Matsumoto, K., Nakamura, T., Orei, L., and Montesano, R. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J Biol. Chem., 267: 20493-20496, 1992.
7. Korczak, B., Kerbel, R. S., and Dennis, J. W. Autocrine and paracrine regulation of tissue inhibitor of metalloproteinases, transin, and urokinase gene expression in metastatic and non-metastatic mammary carcinoma cells. Cell Growth & Differ., 2: 335-341, 1991.
8. Borchers, A. H., Powell, M. B., Fusenig, N , and Bowden, G T Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant keratinocyte/dermal fibroblast cocultures. Exp Cell Res., 213: 143-147, 1994.
9. Pyke, C , Kristensen, P , Ralfakiaer, E., Eriksen, J., and Dano, K. The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res , 51: 4067-4071, 1991.
10. Stacey, D. W., Roudebush, M , Day, R., Mosser, S. D., Gibbs, J B., and Feig, L. A. Dominant inhibitory ras mutants demonstrate the requirement for ras activity in the action of tyrosine kinase oncogenes Oncogene, 6: 2297-2304, 1991
11. Minden, A., Lin, A., McMahon, M , Lange-Carter, C., Derijard, B., Davis, R. J., Johnson, G. L., and Karin, M. Differential activation of ERK and JNK mitogen-activated protein kinases by raf-1 and MEKK. Science (Washington DC), 266: 1719-1722, 1994.
12. Bruder, J. T. Heidecker, G., and Rapp, U. R. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase Genes Dev., 6: 545-556, 1992.
13. Crews, C M , Alessandrini, A , and Erikson, R L. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product Science (Washington DC), 258: 478-480, 1992.
14. Lengyel, E., Gum, R., Stepp, E., Juarez, J., Wang, H , and Boyd, D. Regulation of urokinase-type plasminogen activator expression by an ERK-1-dependent signaling pathway in a squamous cell carcinoma cell line J Cell. Biochem., 61: 430-443, 1996.
15. Dudley, D. T , Pang, L., Decker, S. J., Bridges, A., and Saltiel, A. R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl. Acad. Sci. USA, 92: 7686-7689, 1995
16. Alessi, D R , Cuenda, A , Cohen, P , Dudley, D. T., and Saltiel, A R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem , 270: 27489-27494, 1995.
17. Servant, M. J., Giasson, E., and Meloche, S Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J. Biol. Chem., 271: 16047-16052, 1996.
18. Mossman, T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytoxicity assays J. Immunol. Methods, 65. 55-63, 1983.
19. erk-2 J Biol. Chem , 270: 269-273, 1995.
20. Schlechte, W., Murano, G , and Boyd, D. D. Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation. Cancer Res., 49: 6064-6069, 1989
21. Sappino, A., Belin, D , Huarte, J , Hirschel-Scholz, S , Saurat, J., and Vassallt, J Differential protease expression by cutaneous squamous and basal cell carcinomas. J Clin. Invest., 88, 1073-1079, 1991
22. Clayman, G., Wang, S W , Nicolson, G. L., El-Naggar, A , Mazar, A., Henkin, J., Blasi, F., Goepfert, H., and Boyd, D Regulation of urokinase-type plasminogen activator expression in squamous cell carcinoma of the oral cavity Int. J. Cancer, 54 73-80, 1993
23. Boxman, I. L. A., Quax, P H A., Clemens, W G. M., Papapoulos, S. E , Verheijen, J., and Ponec, M. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts. J Invest. Dermatol , 104: 374-378, 1995.
24. Jeffers, M., Rong, S., and Vande Woude, G. F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol., 16: 1115-1125, 1996.
25. Jensen, P J , and Rodeck, U. Autocrine/paracrine regulation of keratinocyte urokinase plasminogen activator through the TGF-a/EGF receptor. J Cell. Physiol., 155: 333-339, 1993
26. FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem., 269, 31807-31813, 1994.
27. Grandis, J., and Tweardy, D. J. Elevated levels of transforming growth factor a and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res , 53: 3579-3584, 1993.
28. r 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res., 50: 3872-3877, 1990
29. Garbisa, S., Scagliotti, G., Di Francesco, C , Caenazzo, C., Onisto, M., Micela, M., Stetler-Stevenson, W G , and Liotta, L. Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy Cancer Res., 52, 4548-4549, 1992.
30. Crawford, H. C., and Matrisian, L. M Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression Invasion & Metastasis, 14: 234-245, 1994.
31. Xuan, J W , Hota, C., Shigeyama, Y., D'Errico, J. A., Somerman, M. J , and Chambers, A. F. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions, J. Cell Biochem., 57: 680-690, 1995.
32. Keski-Oja, J., Blasi, F., Leof, E. B., and Moses, H. L. Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-b J. Cell Biol , 106. 451-459, 1988.
33. Collart, M., Belin, D., Vassalli, J , Kossodo, S., and Vassalli, P Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachetin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med., 164 2113-2118, 1986
34. Georg, B., Helseth, E., Lund, L. R., Skandsen, T , Riccio, A., Dano, K., Unsgaard, G., and Andreasen, P A. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines Mol Cell. Endocrinol , 61 87-96, 1989.
35. Niedbala, M J., and Picarella, M. S Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonisin by gamma-interferon. Blood, 79. 678-687, 1992.
36. Shibuya, H., Yamaguchi, K., Shirakabe, K., Tonegawa, A., Gotoh, Y., Ueno, N , Irie, K., Nishida, E., and Matsumoto, K. TAB1, an activator of the TAK1 MAPKKK in TGF-b signal transduction Science (Washington DC), 272: 1179-1182, 1996.
37. Moriguchi, T., Kuroyanagi, N , Yamaguchi, K., Gotoh, Y., Iric, K., Kano, T., Shirakabe, K , Muro, Y., Shibuya, H., Matsumoto, K., Nishida, E , and Hagiwara, M. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol Chem., 271: 13675-13679, 1996.
38. Karin, M. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin. Cell Biol., 6: 415-424, 1994
39. Westwick, J. K., Bielawska, A. E., Dbaibo, G., Hannun, Y. A., and Brenner, D A Ceramide activates the stress-activated protein kinases. J. Biol. Chem , 270: 22689-22692, 1995
40. Hirano, M , Osada, S , Aoki, T , Hirai, S., Hosaka, M., Inoue, J., and Ohno, S MEK kinase is involved in tumor necrosis factor α-induced NF-κB activation and degradation of IκB-α. J. Biol. Chem., 271 13234-13238, 1996.
41. Oka, H., Chatani, Y., Hoshino, R , Ogawa, O., Kakehi, Y., Terachi, T., Okdada, Y , Kawaichi, M , Kohno, M., and Yoshida, O. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res , 55 4182-4187, 1995.